Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Jan 15, 2018; 10(1): 31-39
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.31
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.31
Figure 3 Kaplan-Meier curves of disease-free survival (A) and overall survival (B) for T4bN1-3M0/TxN3bM0 gastric cancer patients after curative gastrectomy according to the duration of adjuvant chemotherapy.
P value by log-rank test. A: Disease-free survival (DFS): 23.2 mo vs 9.9 mo, P = 0.0001; B: Overall survival: 40.2 mo vs 21.6 mo, P = 0.001. CT: Chemotherapy.
- Citation: Wang QW, Zhang XT, Lu M, Shen L. Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer. World J Gastrointest Oncol 2018; 10(1): 31-39
- URL: https://www.wjgnet.com/1948-5204/full/v10/i1/31.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i1.31